Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arne Christians

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|December 13, 2022
Highly Multiplexed Immunofluorescence Imaging for Quantitative Spatial Analysis in Tissue Samples with ChipCytometry™Thomas D Campbell, Arne Christians, Madison A Tyler
Acta Neuropathologica Communications|December 17, 2017
Absence of MGMT promoter methylation in diffuse midline glioma, H3 K27M-mutantRouzbeh Banan, Arne Christians, Stephan Bartels, et al.
International Journal of Cancer|January 8, 2019
Characterization of the epithelial membrane protein 3 interaction network reveals a potential functional link to mitogenic signal transduction regulationArne Christians, Eric Poisel, Christian Hartmann, et al.
Analytica Chimica Acta|March 28, 2007
Modification of mRNA expression after treatment with anabolic agents and the usefulness for gene expression-biomarkersMartina Reiter, Vanessa M Walf, Arne Christians, et al.
International Journal of Molecular Sciences|January 27, 2021
In-Depth Immune-Oncology Studies of the Tumor Microenvironment in a Humanized Melanoma Mouse ModelJonathan Schupp, Arne Christians, Niklas Zimmer, et al.
Acta Neurochirurgica|September 12, 2018
Cerebellar glioblastoma: a clinical series with contemporary molecular analysisBujung Hong, Rouzbeh Banan, Arne Christians, et al.
Plos One|March 20, 2012
Prognostic value of three different methods of MGMT promoter methylation analysis in a prospective trial on newly diagnosed glioblastomaArne Christians, Christian Hartmann, Axel Benner, et al.
Brain Pathology (Zurich, Switzerland)|September 12, 2009
PCR- and restriction endonuclease-based detection of IDH1 mutationsJochen Meyer, Stefan Pusch, Jörg Balss, et al.
Acta Neuropathologica|June 23, 2009
Combined molecular analysis of BRAF and IDH1 distinguishes pilocytic astrocytoma from diffuse astrocytomaAndrey Korshunov, Jochen Meyer, David Capper, et al.
Diagnostic Pathology|June 29, 2016
Frequency of BRAF V600E mutations in 969 central nervous system neoplasmsFelix Behling, Alonso Barrantes-Freer, Marco Skardelly, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Methods in Molecular Biology (Clifton, N.J.)|December 13, 2022
Highly Multiplexed Immunofluorescence Imaging for Quantitative Spatial Analysis in Tissue Samples with ChipCytometry™Thomas D Campbell, Arne Christians, Madison A Tyler
Acta Neuropathologica Communications|December 17, 2017
Absence of MGMT promoter methylation in diffuse midline glioma, H3 K27M-mutantRouzbeh Banan, Arne Christians, Stephan Bartels, et al.
International Journal of Cancer|January 8, 2019
Characterization of the epithelial membrane protein 3 interaction network reveals a potential functional link to mitogenic signal transduction regulationArne Christians, Eric Poisel, Christian Hartmann, et al.
Analytica Chimica Acta|March 28, 2007
Modification of mRNA expression after treatment with anabolic agents and the usefulness for gene expression-biomarkersMartina Reiter, Vanessa M Walf, Arne Christians, et al.
International Journal of Molecular Sciences|January 27, 2021
In-Depth Immune-Oncology Studies of the Tumor Microenvironment in a Humanized Melanoma Mouse ModelJonathan Schupp, Arne Christians, Niklas Zimmer, et al.
Acta Neurochirurgica|September 12, 2018
Cerebellar glioblastoma: a clinical series with contemporary molecular analysisBujung Hong, Rouzbeh Banan, Arne Christians, et al.
Plos One|March 20, 2012
Prognostic value of three different methods of MGMT promoter methylation analysis in a prospective trial on newly diagnosed glioblastomaArne Christians, Christian Hartmann, Axel Benner, et al.
Brain Pathology (Zurich, Switzerland)|September 12, 2009
PCR- and restriction endonuclease-based detection of IDH1 mutationsJochen Meyer, Stefan Pusch, Jörg Balss, et al.
Acta Neuropathologica|June 23, 2009
Combined molecular analysis of BRAF and IDH1 distinguishes pilocytic astrocytoma from diffuse astrocytomaAndrey Korshunov, Jochen Meyer, David Capper, et al.
Diagnostic Pathology|June 29, 2016
Frequency of BRAF V600E mutations in 969 central nervous system neoplasmsFelix Behling, Alonso Barrantes-Freer, Marco Skardelly, et al.
Pageof 2